Screening clopidogrel non-responders and optimizing antiplatelet therapy after acute and elective percutaneous coronary intervention

被引：0
|
作者：
Lee, S. [1 ]
Vargova, K. [2 ]
Hizoh, I. [2 ]
Gulacsi-Bardos, P. [1 ]
Horvath, Z. S. [1 ]
Kovacs, A. [1 ]
Toth-Zsamboki, E. [2 ]
Preda, I. [2 ]
Kiss, R. G. [2 ]
机构：
[1] Hungarian Acad Sci, Res Grp Inflammat Biol & Immunogen, Budapest, Hungary
[2] State Hlth Ctr, Dept Cardiol, Budapest, Hungary
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 50 条
  • [41] Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using DrugEluting Stent
    Lee, Seung Hun
    Hong, David
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Hahn, Joo-Yong
    Hong, Young Joon
    Kim, Ju Han
    Kim, Byeong-Keuk
    Joo, Hyung Joon
    Chang, Kiyuk
    Park, Yongwhi
    Ahn, Sung Gyun
    Suh, Jung-Won
    Lee, Sang Yeub
    Cho, Jung Rae
    Her, Ae-Young
    Jeong, Young-Hoon
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Lim, Do-Sun
    Shin, Eun-Seok
    Ahn, Youngkeun
    Choi, Seung-Hyuck
    Gwon, Hyeon-Cheol
    Jeong, Myung Ho
    Song, Young Bin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B13 - B13
  • [42] Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention
    Yamamoto, Ko
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Obayashi, Yuki
    Natsuaki, Masahiro
    Yamaji, Kyohei
    Domei, Takenori
    Ogita, Manabu
    Ohya, Masanobu
    Tatsushima, Shojiro
    Suzuki, Hirohiko
    Tada, Tomohisa
    Ishii, Mitsuru
    Nikaido, Akira
    Watanabe, Naoki
    Fujii, Shinya
    Mori, Hiroyoshi
    Nishikura, Tenjin
    Suematsu, Nobuhiro
    Hayashi, Fujio
    Komiyama, Kota
    Shigematsu, Tatsuya
    Isawa, Tsuyoshi
    Suwa, Satoru
    Ando, Kenji
    Kimura, Takeshi
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (01) : 19 - 31
  • [43] Oral Anticoagulants With Dual Antiplatelet Therapy Versus Clopidogrel in Patients After Percutaneous Coronary Intervention: A Meta-Analysis
    Palla, Mohan
    Briasoulis, Alexandros
    Kondur, Ashok
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (01) : E143 - E150
  • [44] Exclusive Antiplatelet Therapy for Percutaneous Coronary Intervention
    Denardo, Scott J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (20) : 1921 - 1922
  • [45] Dual antiplatelet therapy after percutaneous coronary intervention: Personalize the duration
    Howard, Travis M.
    Khot, Umesh N.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (06) : 325 - 332
  • [46] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [47] EFFICACY OF RECTAL DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Nowrozi, Arian
    Kim, Michael
    Gavrilos, George
    Hadley, Sydney
    Kabbany, Mohammad
    CRITICAL CARE MEDICINE, 2024, 52
  • [48] Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes
    Paciullo, Francesco
    Gresele, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [49] Oral antiplatelet therapy and percutaneous coronary intervention
    Yan, BPY
    Clark, DJ
    Ajani, AE
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) : 3 - 12
  • [50] Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk
    Spinler, Sarah A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S7 - S17
12345